KYMR Stock Summary and Trading Ideas (Kymera Therapeutics | NASDAQ:KYMR)

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.

What symbol and exchange does Kymera Therapeutics shares trade?

Kymera Therapeutics trades on the NASDAQ stock market under the symbol KYMR.

What is Kymera Therapeutics stock price doing today?

As of September 8, 2026, KYMR stock price declined to $116.47 with 606,514 million shares trading.

What is Kymera Therapeutics's Beta?

KYMR has a beta of 0.72, meaning it tends to be less sensitive to market movements. KYMR has a correlation of 0.03 to the broad based SPY ETF.

How much is Kymera Therapeutics worth?

KYMR has a market cap of $9.68 billion. This is considered a Mid Cap stock.

How much money does Kymera Therapeutics make?

Last quarter Kymera Therapeutics reported $65 million in Revenue and -$.62 earnings per share. This beat revenue expectation by $32 million and exceeded earnings estimates by $.10.

What is the highest and lowest price Kymera Therapeutics traded in the last 3 year period?

In the last 3 years, KYMR traded as high as $130.05 and as low as $9.60.

What are the top ETFs holding Kymera Therapeutics?

The top ETF exchange traded funds that KYMR belongs to (by Net Assets): VTI, XBI, VB, VBK, VXF.

Is Kymera Therapeutics (KYMR) a good investment?

KYMR has outperformed the market in the last year with a return of +169.2%, while the SPY ETF gained +19.2%. In the last 3 month period, KYMR beat the market returning +57.5%, while SPY returned +3.9%. However, in the most recent 2 weeks KYMR has underperformed the stock market by returning -8.0%, while SPY returned 0.0%.

What are the support and resistance levels for Kymera Therapeutics (KYMR)?

KYMR support price is $113.93 and resistance is $120.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that KYMR shares will trade within this expected range on the day.